53631-13-3

Usage

Uses

Used in Organic Synthesis:
Ethanone, 2-bromo-1-(3,5-dichlorophenyl)(Related Reference) is used as a precursor in organic synthesis for the creation of various chemical compounds. Its unique structure, including the bromine and 3,5-dichlorophenyl groups, allows for specific reactions and transformations that can be beneficial in the synthesis of target molecules.
Used in Research Applications:
In the field of scientific research, Ethanone, 2-bromo-1-(3,5-dichlorophenyl)(Related Reference) serves as a reagent for studying chemical reactions and mechanisms. Its presence in a reaction system can provide insights into the behavior of similar compounds and contribute to the understanding of organic chemistry.
Used in Pharmaceutical Industry:
Ethanone, 2-bromo-1-(3,5-dichlorophenyl)(Related Reference) may be utilized in the pharmaceutical industry as an intermediate in the synthesis of drugs or drug candidates. Its unique functional groups can be exploited to create molecules with specific biological activities, potentially leading to the development of new therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, Ethanone, 2-bromo-1-(3,5-dichlorophenyl)(Related Reference) could be employed as a building block for the synthesis of agrochemicals, such as pesticides or herbicides. Its chemical properties may contribute to the development of effective and environmentally friendly products for agricultural use.
Used in Material Science:
Ethanone, 2-bromo-1-(3,5-dichlorophenyl)(Related Reference) may also find applications in material science, where it could be used to develop new materials with specific properties. Its unique structure and reactivity could be harnessed to create materials with improved performance in various applications, such as coatings, adhesives, or polymers.

Upstream product

• 14401-72-0 3',5'-dichloroacetophenone 
• 2905-62-6 3,5-dichlorobenzoyl chloride 

Downstream Products

• 154260-27-2 1-(3,5-dichlorophenyl)-2-methylthio-1-ethanone 
• 1444617-06-4 C₂₅H₁₇Cl₂NO₄ 

Relevant academic research and scientific papers

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

Azabicyclo derivative and preparation method therefor and application thereof

The invention relates to an azabicyclo derivative and a preparation method therefor and an application thereof. Specifically, the invention discloses a compound with a structure represented by a formula (A) or salts acceptable in pesticide science thereof, wherein the compound represented by the formula (A) is as shown in the description. The compound has an excellent killing effect on nematodes.

Fungicidal arylpyrazoles

The present invention relates to new derivatives of the family of 3-arylpyrazoles of formula (I), their methods of preparation, the compositions containing them and their utilization for the protection of plants against fungal diseases. STR1

Analogues of 4,5-bis(3,5-dichlorophenyl)-2-trifluoromethyl-1H-imidazole as potential antibacterial agents

A preliminary exploration of analogues of 4,5-bis(3,5-dichlorophenyl)- 2-trifluoromethyl-1H-imidazole, 1, as novel antibacterial agents was carried out to determine the basic features of the structure responsible for the observed biological activity. The presence of two aryl rings, the imidazole NH and either a good electron withdrawing group or an aldehyde or amino group at C-2 were required for good levels of activity against methicillin resistant Staphylococcus aureus (MRSA).

Process for producing optically active carbinols

The present invention relates to a process for producing optically active halomethyl phenyl carbinols of the formula (1), comprising reducing halomethyl phenyl ketones of the formula (2) using an asymmetric reducing agent obtained from boranes and optically active α-phenyl-substituted-β-amino alcohols of the formula (3) or optically active α-non-substituted-β-amino alcohols of the formula (4). The present invention further relates to a process for producing optically active carbinols, comprising reacting a prochiral keytone with an asymmetric reducing agent obtained from optically active β-amino alcohols of the formula (5), a metal boron hydride and Lewis acid or lower dialkyl sulfuric acid. All of the formulas (1) to (5) are the same as shown in the specification.